|
Q3 2021
Filed on Nov 09, 2021
|
28,960
|
N/A
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
66,274
|
$39.86 - $40.36
$2.64M - $2.67M
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
34
|
N/A
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
2,532
|
$3.57 - $5.6
$9.04K - $14.2K
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
81,012
|
$6.63 - $7.12
$537K - $577K
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
1,097
|
$121.72 - $133.34
$134K - $146K
|
|
Catabasis Pharmaceuticals In
|
Q3 2021
Filed on Nov 09, 2021
|
5,311
|
N/A
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
11
|
$1.78 - $3.23
$19.6 - $35.5
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
1,736
|
$82.58 - $91.94
$143K - $160K
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
4,000
|
$13.79 - $14.94
$55.2K - $59.8K
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
500
|
$15.09 - $16.56
$7.55K - $8.28K
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
271
|
N/A
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
396
|
$50.57 - $53.3
$20K - $21.1K
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
200
|
$74.5 - $80.26
$14.9K - $16.1K
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
3,875
|
$120.0 - $131.29
$465K - $509K
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
23,127
|
$46.43 - $49.91
$1.07M - $1.15M
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
79,318
|
$32.62 - $34.39
$2.59M - $2.73M
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
1,015
|
$86.58 - $94.0
$87.9K - $95.4K
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
15,494
|
$42.3 - $44.68
$655K - $692K
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
72,155
|
$52.52 - $55.82
$3.79M - $4.03M
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
35,938
|
$21.76 - $23.48
$782K - $844K
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
109,318
|
$33.35 - $35.56
$3.65M - $3.89M
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
690
|
$50.23 - $53.1
$34.7K - $36.6K
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
687
|
$48.09 - $52.25
$33K - $35.9K
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
316
|
$94.94 - $101.67
$30K - $32.1K
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
424
|
$60.31 - $64.02
$25.6K - $27.1K
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
238
|
N/A
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
342
|
$100.54 - $106.29
$34.4K - $36.4K
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
20,058
|
$38.21 - $40.67
$766K - $816K
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
261
|
$83.18 - $91.93
$21.7K - $24K
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
2,459
|
$70.37 - $75.16
$173K - $185K
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
35
|
$172.65 - $267.23
$6.04K - $9.35K
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
3,278
|
$84.6 - $98.65
$277K - $323K
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
2,776
|
$65.61 - $75.33
$182K - $209K
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
213
|
N/A
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
91
|
N/A
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
115
|
$50.36 - $65.22
$5.79K - $7.5K
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
65
|
$33.46 - $42.76
$2.17K - $2.78K
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
621
|
$40.99 - $45.14
$25.5K - $28K
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
460
|
$41.85 - $44.21
$19.3K - $20.3K
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
1,255
|
$26.13 - $29.21
$32.8K - $36.7K
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
227
|
$90.04 - $100.03
$20.4K - $22.7K
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
196
|
$24.91 - $26.31
$4.88K - $5.16K
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
59
|
$67.32 - $74.23
$3.97K - $4.38K
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
1
|
$56.07 - $59.24
$56.1 - $59.2
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
86
|
$13.9 - $15.09
$1.2K - $1.3K
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
35,669
|
$28.53 - $29.97
$1.02M - $1.07M
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
4,000
|
$21.89 - $25.16
$87.6K - $101K
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
1,600
|
$31.7 - $32.43
$50.7K - $51.9K
|
|
Invesco Dynamic Cr Opportuni
|
Q3 2021
Filed on Nov 09, 2021
|
36,312
|
N/A
|
|